Price T Rowe Associates Inc. MD Increases Stock Holdings in Masimo Co. (NASDAQ:MASI)

Price T Rowe Associates Inc. MD boosted its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 259.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 250,786 shares of the medical equipment provider's stock after buying an additional 181,070 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.47% of Masimo worth $41,456,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in MASI. Hsbc Holdings PLC purchased a new stake in shares of Masimo during the fourth quarter worth about $912,000. Tower Research Capital LLC TRC lifted its holdings in Masimo by 141.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,588 shares of the medical equipment provider's stock worth $428,000 after buying an additional 1,515 shares during the period. MetLife Investment Management LLC grew its position in shares of Masimo by 9.3% in the 4th quarter. MetLife Investment Management LLC now owns 26,026 shares of the medical equipment provider's stock worth $4,302,000 after buying an additional 2,214 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Masimo during the fourth quarter valued at approximately $163,000. Finally, Capital Research Global Investors raised its holdings in shares of Masimo by 80.5% during the fourth quarter. Capital Research Global Investors now owns 2,454,975 shares of the medical equipment provider's stock valued at $405,807,000 after acquiring an additional 1,094,647 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on MASI shares. Piper Sandler upped their price objective on shares of Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Wells Fargo & Company raised their price objective on shares of Masimo from $193.00 to $205.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a report on Thursday, April 10th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $194.80.

Insider Activity at Masimo

In related news, Director Craig B. Reynolds sold 2,053 shares of Masimo stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the completion of the sale, the director now directly owns 16,581 shares in the company, valued at approximately $2,754,601.53. This trade represents a 11.02 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the sale, the chief operating officer now directly owns 24,172 shares in the company, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is owned by insiders.

Masimo Stock Up 1.7 %

Shares of MASI stock traded up $2.77 during trading hours on Friday, hitting $166.42. 511,618 shares of the company's stock traded hands, compared to its average volume of 662,613. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 114.77 and a beta of 1.28. The stock's fifty day simple moving average is $164.74 and its two-hundred day simple moving average is $166.13. Masimo Co. has a 12-month low of $101.61 and a 12-month high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.38. The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. On average, analysts expect that Masimo Co. will post 4.1 EPS for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.